A combined analysis of data from five different tumors in TCGA revealed that patients with low CDKN2A expression had a better prognosis, with hepatocellular carcinoma and lung squamous carcinoma reaching significant levels (Figure 6n; Supplementary Figure S5). Here, CDKN2A is linked to hepatocellular carcinoma.